MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Aduro BioTech Company Profile (NASDAQ:ADRO)

Consensus Ratings for Aduro BioTech (NASDAQ:ADRO) (?)
Ratings Breakdown: 1 Sell Rating(s), 1 Hold Rating(s), 5 Buy Rating(s)
Consensus Rating:Buy (Score: 2.57)
Consensus Price Target: $24.17 (139.27% upside)

Analysts' Ratings History for Aduro BioTech (NASDAQ:ADRO)
Show:
DateFirmActionRatingPrice TargetActions
6/6/2016FBR & Co.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/16/2016Roth CapitalReiterated RatingBuy$46.00 -> $22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/16/2016Canaccord GenuityReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/17/2016Leerink SwannReiterated RatingOutperform$48.00 -> $14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/15/2016Bank of AmericaDowngradeBuy -> Underperform$32.00 -> $14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/2/2016William BlairInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/1/2015OppenheimerDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/27/2014 forward)
Earnings History for Aduro BioTech (NASDAQ:ADRO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/8/2016        
5/2/2016Q116($0.25)($0.45)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/8/2016Q415($0.15)$0.04$34.38 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/24/2015Q3($0.08)$0.01$15.80 million$19.15 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/10/2015Q215($0.01)($0.50)$1.00 million$9.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/28/2015Q115($0.03)($39.97)$9.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Aduro BioTech (NASDAQ:ADRO)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20168($0.52)($0.10)($0.29)
Q2 20167($0.46)$0.11($0.18)
Q3 20167($0.51)($0.20)($0.43)
Q4 20167($0.56)($0.21)($0.44)
Q1 20171($0.50)($0.50)($0.50)
Q2 20171($0.51)($0.51)($0.51)
Q3 20171($0.51)($0.51)($0.51)
Q4 20171($0.51)($0.51)($0.51)
(Data provided by Zacks Investment Research)
Dividend History for Aduro BioTech (NASDAQ:ADRO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Aduro BioTech (NASDAQ:ADRO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/16/2016Thomas W. DubenskyInsiderSell905$8.20$7,421.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/11/2016Dirk G. BrockstedtVPSell22,000$21.77$478,940.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/8/2016Gregory W. SchaferCOOSell20,000$23.58$471,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/6/2016Jennifer LewVPSell5,242$25.71$134,771.82View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/5/2016Stephen T. IsaacsCEOSell25,000$26.31$657,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/4/2016Thomas W. DubenskyinsiderSell15,000$26.37$395,550.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/7/2015Gregory W. SchaferCOOSell25,000$29.74$743,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/3/2015Jennifer LewVPSell5,242$29.85$156,473.70View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/1/2015Stephen T. IsaacsCEOSell25,000$29.11$727,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/1/2015Thomas W. DubenskyinsiderSell30,000$29.27$878,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/18/2015Jennifer LewVPSell6,712$28.52$191,426.24View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/17/2015Gregory W. SchaferCOOSell26,470$28.15$745,130.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/17/2015Thomas W. DubenskyinsiderSell31,470$28.27$889,656.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/16/2015Stephen T. IsaacsCEOSell25,000$27.54$688,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/20/2015Jennifer LewVPBuy2,000$17.00$34,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/20/2015Venture (Vi) Inves MorningsideMajor ShareholderBuy441,176$17.00$7,499,992.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/20/2015William Mariner GreenmanDirectorBuy3,000$17.00$51,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Aduro BioTech (NASDAQ:ADRO)
DateHeadline
06/25/16 09:44 AMAduro Biotech Incorporated (NASDAQ:ADRO) Shorted Shares Increased 14.17% After Market Selling - Engelwood Daily
06/25/16 09:44 AMTwo Stocks within Analysts Limelight: Aduro Biotech, Inc. (NASDAQ:ADRO) , Trevena, Inc. (NASDAQ:TRVN) - Street Updates
06/23/16 10:03 AMAduro BioTech : Healthcare Sector Equities Under the Scanner - Alkermes, AMAG Pharma, IDEXX Laboratories, and Aduro BioTech
06/21/16 07:05 AMAduro Biotech, Inc. (NASDAQ:ADRO) Current Analyst Ratings - Fiscal Standard
06/21/16 03:29 AMBHP Billiton targets another $US600 million from coal arm by June 2017 - [at noodls] - Man pleads guilty to posting abusive comments about Nova Peris on Facebook Mining giant BHP Billiton says it is aiming to earn another $US600 million from its coal business by the end of the 2017 financial ...
06/20/16 02:18 PMStrong Buy Calls Count For Aduro BioTech Inc (NASDAQ:ADRO) At 4 - Investor Newswire
06/19/16 07:05 AMAduro Biotech, Inc. (NASDAQ:ADRO) Analyst Price Targets For The Coming Week - Fiscal Standard
06/16/16 06:28 AMAduro BioTech Inc (NASDAQ:ADRO) Yearly Sales Estimate At $212.495 - Investor Newswire
06/15/16 02:19 PMLuna Innovations Incorporated (NASDAQ:LUNA) Rose 5.36%: Aduro BioTech, Inc. (NASDAQ:ADRO), Bankrate, Inc ... - KC Register
06/15/16 05:59 AMOPEC Has Its Way as China Oil Output Cut by Most in 15 Years - [at noodls] - China's crude production dropped by the most in 15 years in another sign that OPEC's strategy of flooding markets to drive out higher-cost suppliers is working in the world's biggest energy consumer. The ...
06/13/16 11:09 PMCoal to Replace Gas as Japan’s Leading Power Source From 2019 - [at noodls] - Coal is set to overtake gas within the next three years as the largest generator of power in Japan as power utilities replace aging nuclear capacity with the fossil fuel, Bloomberg New Energy Finance said. ...
06/13/16 10:39 PMChina Cuts Oil Output by Most in 15 Years, Coal Production Slows - [at noodls] - (Bloomberg) - China cut crude production by the most in 15 years as producers shut higher cost fields. The world's second-largest oil consumer reduced oil output in May by 7.3 percent from a year ago to ...
06/13/16 03:19 AMShare Sale Agreement for IMC - [at noodls] - PT Alam Tri Abadi, Coaltrade Services International Pte Ltd (both are subsidiaries of PT Adaro Energy Tbk), and BHP Minerals Holdings Pty. Ltd. and BHP Minerals Asia Pacific Pty. Ltd. have signed Share ...
06/13/16 03:19 AMFinancial Close of PT Bhimasena Power Indonesia - [at noodls] - Financial Close of PT Bhimasena Power Indonesia The text version of this document is not available at the moment. The original content was posted at original link . PT Adaro Energy Tbk published this content ...
06/12/16 07:36 PMTrend Of Rating Given To Aduro BioTech Inc (NASDAQ:ADRO) - Investor Newswire
06/10/16 03:12 PMADURO BIOTECH, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
06/09/16 07:48 AMSurging Earnings Estimates Signal Good News for Aduro BioTech (ADRO) -
06/09/16 07:19 AMAduro Biotech to Present at NASDAQ Investor Conference - [at noodls] - BERKELEY, Calif., June 09, 2016 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ:ADRO) today announced that Stephen T. Isaacs, chairman, president and chief executive officer of Aduro, will present at the ...
06/08/16 12:58 AMFinancial Close Bhimasena Power Indonesia - [at noodls] - ADRJKKMP2201-20160608114017 No Attachment AE/072NI-16/MP/aps Jakarta, June 8, 2016 To: Chief Executive of the Capital Market Supervisory Financial Services Authority Gedung Sumitro Djojohadikusumo JI. ...
06/07/16 07:03 AMAduro BioTech, Inc. breached its 50 day moving average in a Bullish Manner : ADRO-US : June 7, 2016 -
06/07/16 04:58 AMShare Sale Agreement for IMC Project - [at noodls] - ADRJKKMP2201-20160607161847 No Attachment AE/071/VI-16/MPIaps Jakarta, June 7, 2016 To: Chief Executive of the Capital Market Supervisory Financial Services Authority Gedung Sumitro Djojohadikusumo JI. ...
06/07/16 12:48 AMHow Indonesia is mining its problems away - [at noodls] - https://govinsider.asia/innovation/how-indonesia-is-mining-its-problems-away/ The Oppenheimer Blue sits in a proportionate cut, emanates azure hues under light, and has been described as 'the Mona Lisa ...
06/07/16 12:48 AMTHERMAL COAL-Market rises as production cuts tackle glut - [at noodls] - European thermal coal prices rose this week, boosted by cuts to production shrinking the supply overhang, while higher oil prices were also supportive. European cargoes for nearby delivery to Amsterdam, ...
06/06/16 11:18 PMCoal producers to raise prices of water-transported products - [at noodls] - Four major coal companies are to raise the price of their coal ready for shipment at ports by 10 yuan ($1.5) per ton during June. Shenhua Group Corp, China Coal Energy Group Co Ltd, Datong Coal Mine Group ...
06/05/16 02:19 PMHow Analysts Rated Aduro BioTech Inc (NASDAQ:ADRO) Last Week? - HNN
06/04/16 08:08 AMAduro Biotech Presents Encouraging Anti-Tumor Response Data From Ongoing Phase 1b Study in Malignant Pleural Mesothelioma at ASCO - [at noodls] - BERKELEY, Calif., June 04, 2016 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq:ADRO) today announced the presentation of updated data from an ongoing Phase 1b clinical trial of its immunotherapy product ...
06/03/16 10:46 AMBuy, Sell Or Hold Rating For Aduro Biotech, Inc. (NASDAQ:ADRO)? - Share Trading News
06/02/16 10:55 AMInvestor News: Aduro BioTech Inc (NASDAQ:ADRO) faces Investigation over potential Violations of Securities Laws - GroundReport - Investor News: Aduro BioTech Inc (NASDAQ:ADRO) faces Investigation over potential Violations of Securities LawsGroundReportAn investigation for investors in NASDAQ:ADRO shares was announced over potential securities laws violations by Aduro BioTech Inc and certain of its directors and officers. Investors who purchased shares of Aduro BioTech Inc (NASDAQ:ADRO), have ...Aduro Biotech Incorporated (NASDAQ:ADRO) Shorts Decreased by 15.41% After Short CoveringFranklin IndependentBroker Watchlist: Aduro Biotech, Inc. (NASDAQ:ADRO)Share Trading Newsall 3 news articles »
06/02/16 06:05 AMChina’s Coal Price Climbs to Eight-Month High Amid Supply Cut - [at noodls] - China's benchmark coal prices climbed to the highest since September as government steps to curb supply amid a glut started to take effect. Spot coal with an energy value of 5,500 kilocalories per kilogram ...
06/02/16 06:05 AMIndonesia says coal output will fall next year - [at noodls] - http://www.miningweekly.com/article/indonesia-says-coal-output-will-fall-next-year-2016-05-30 Indonesia expects its coal production to edge down in 2017, as smaller miners cut output due to lower prices ...
06/01/16 10:41 AMStock Review and Earnings Check on Aduro BioTech Inc (NASDAQ:ADRO) - HNN - Stock Review and Earnings Check on Aduro BioTech Inc (NASDAQ:ADRO)HNNCompany earnings are a good way to evaluate the company profitability. Currently, sell-side analysts are expecting Aduro BioTech Inc (NASDAQ:ADRO) to report quarterly EPS of $-0.05. The company's next earnings report is expected to be published on or ...and more »
05/31/16 02:19 PMStrong Sell Calls Count For Aduro BioTech Inc (NASDAQ:ADRO) At 0 - Investor Newswire - Strong Sell Calls Count For Aduro BioTech Inc (NASDAQ:ADRO) At 0Investor NewswireThe Sell calls on Aduro BioTech Inc (NASDAQ:ADRO) were 1. Two months earlier 4 were the Strong Buy calls whereas Strong Sell calls were 0. During this period, the hold calls were 0. The buy recommendations were 0 and sell calls count was 1. Analyst ...and more »
05/30/16 05:40 AMWhy coal is a bad bet for Indonesia’s future - [at noodls] - http://www.thejakartapost.com/academia/2016/05/26/why-coal-is-a-bad-bet-for-indonesias-future.html This month, across the world, people are standing up for a future without fossil fuels. The Break Free ...
05/29/16 10:56 AMAduro BioTech Inc (NASDAQ:ADRO) EPS Estimate At $-0.47 - RealistInvestor.com - Aduro BioTech Inc (NASDAQ:ADRO) EPS Estimate At $-0.47RealistInvestor.comThe EPS projection of Aduro BioTech Inc (NASDAQ:ADRO) for quarter ended 2016-09-30 is $-0.47. A week earlier, the EPS target was $-0.47 against target of $-0.47, a month earlier. This target stood at $-0.47 60 days ago against estimate of $-0.47 90 ...
05/26/16 10:16 AMYesterday Stock's Trend Overview: Radius Health, Inc. (NASDAQ:RDUS) , Aduro Biotech, Inc. (NASDAQ:ADRO) - Street Updates - Yesterday Stock's Trend Overview: Radius Health, Inc. (NASDAQ:RDUS) , Aduro Biotech, Inc. (NASDAQ:ADRO)Street UpdatesOn 5/25/2016, shares of Radius Health, Inc. (NASDAQ:RDUS) fell -2.13% in trading session and finally closed at $34.90. The company most recent volume stood at 458.09 thousand shares as compared to its average volume of 1.07 million shares. Over the ...and more »
05/26/16 05:37 AMChina’s Coal Prices to Rise 20% Amid Production Cuts, Citi Says - [at noodls] - China's coal price may rise 20 percent by the end of this year as government steps to reduce production outpace a decline in demand, according to Citigroup Inc. ... This is an abstract of the original ...
05/26/16 05:17 AMJapan, Germany Lead G7 as Sources of Coal Financing, Study Says - [at noodls] - Japan was the leading source of coal financing among Group of Seven nations in the nine years ended in 2015, accounting for more than half of all support from governments or quasi-government bodies, according ...
05/26/16 05:17 AMChina seeks coal production capacity cuts by state-owned companies - [at noodls] - Singapore (Platts)-19 May 2016 536 am EDT/936 GMT Following a clampdown on illegal mines, China has now asked state-owned coal companies to cut their capacity by 10% and improve their efficiency, the Ministry ...
05/25/16 03:06 AMAnalysis: Surge in semi-soft coal volumes pressure Asian coal prices, threatens rally - [at noodls] - Singapore (Platts)-16 May 2016 419 am EDT/819 GMT The recent strength in steel prices, relative to power generation, has prompted coal producers to focus on producing semi-soft coal from thermal coal, ...
05/20/16 07:03 AMMining deals plummet in value as commodities bust continues - [at noodls] - The end of the mining boom and lower commodity prices are continuing to hit the global mining industry hard as the world's biggest miners sell off unprofitable mines and troubled miners sell assets to ...
05/18/16 09:16 PMETF’s with exposure to Aduro BioTech, Inc. : May 19, 2016 -
05/18/16 06:42 AMChinese Coal Giant’s Emissions to Fall after Upgrades - [at noodls] - BEIJING, May 12, 2016 /PRNewswire/ - China's largest coal producer Shenhua Group has completed upgrades to its coal-fired power plants in the Beijing-Tianjin-Hebeiregion that will dramatically reduce their ...
05/17/16 12:46 PMAduro BioTech, Inc. :ADRO-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/17/16 09:00 AMSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Aduro BioTech, Inc. (ADRO) - [Accesswire] - NEW YORK, NY / ACCESSWIRE / May 17, 2016 / Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Aduro BioTech, Inc. ("Aduro" ...
05/16/16 05:48 PMIMPORTANT INVESTOR ALERT: Goldberg Law PC Announces An Investigation of Claims Against Aduro BioTech, Inc. And Advises Investors With Losses To Contact The Firm - [Business Wire] - Goldberg Law PC announces that it is investigating claims of potential misrepresentations by Aduro BioTech, Inc. .
05/16/16 04:52 PMSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Into Possible Securities Fraud Violations by Certain Officers and Directors of Audro BioTech, Inc. - [Business Wire] - Levi & Korsinsky announces it has commenced an investigation of Audro BioTech, Inc. concerning possible violations of federal securities laws.
05/16/16 01:06 PMSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aduro BioTech, Inc. - ADRO - [PR Newswire] - NEW YORK, May 16, 2016 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Aduro BioTech, Inc. ("Aduro" or the "Company") (ADRO). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980. On May 16, 2016, pre-market, the Company announced that its pancreatic cancer drug missed the primary endpoint in a Phase 2b clinical trial.
03/05/16 01:38 PMStock Rating & Analysis on Aduro BioTech Inc (NASDAQ:ADRO) - WallStreet.org - Stock Rating & Analysis on Aduro BioTech Inc (NASDAQ:ADRO)WallStreet.orgAduro BioTech Inc (NASDAQ:ADRO) company shares are recently being watched closely by Wall Street professionals and certain individuals that give personal stock ratings (crowd). Although company fundamentals are important when predicting future stock ...and more »
03/04/16 01:51 PMWhat's in Store for Avalanche (AAVL) This Earnings Season? - Aduro BioTech, Inc. ADRO has an Earnings ESP of +271.40% and a Zacks Rank #2. Marinus Pharmaceuticals, Inc. MRNS has an Earnings ESP of +18.4% and a Zacks Rank #2. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 ...
03/02/16 04:56 AMCoverage initiated on Aduro Biotech by FBR Capital -
About Aduro BioTech

Aduro BioTech logoAduro Biotech, Inc. is a clinical-stage immunotherapy company, which focuses on the discovery, development and commercialization of therapies that manage the treatment of various diseases. Its technologies are based on live, attenuated, double-deleted Listeria mononcytogenes (LADD) and cyclic dinucleotides (CDNs). It also develops LADD-based products, both as monotherapies and in combination with conventional cancer treatments. Its LADD technology platform is based on attenuated strains of Listeria that are engineered to express tumor-associated antigens to induce specific and targeted immune responses. Its CDN platform activates the intracellular stimulator of interferon genes (STING) receptor resulting in a tumor-specific immune response. Its B-select Antibody platform technology is based on in vitro clonal expansion of antibody producing cells (B cells) isolated from the spleen or lymph nodes of immunized mice, followed by immortalization of selected B cells through electro fusion.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ADRO
  • CUSIP:
Key Metrics:
  • Previous Close: $10.93
  • 50 Day Moving Average: $11.27
  • 200 Day Moving Average: $16.13
  • P/E Ratio: N/A
  • P/E Growth: 0.18
  • Market Cap: $652.57M
  • Current Quarter EPS Consensus Estimate: $-1.24 EPS
Additional Links:
Aduro BioTech (NASDAQ:ADRO) Chart for Monday, June, 27, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha